-
Viking Global Opportunities Illiquid Investments Sub-Master LP
2023/03/11
1450000
-500000
2023-03-11
0001725160
0001725160
950000
-
Voliotis Dimitris
2023/03/10
SVP, Clinical Development
119563
-30601
2023-03-10
0001725160
0001725160
88962
-
Epperly Melissa B,
2023/03/09
Chief Financial Officer
459293
-94611
2023-03-09
0001725160
0001725160
364682
-
Epperly Melissa B,
2023/03/08
Chief Financial Officer
459293
-94611
2023-03-08
0001725160
0001725160
364682
-
Epperly Melissa B,
2023/03/07
Chief Financial Officer
459293
-94611
2023-03-07
0001725160
0001725160
364682
-
Gallagher Cam
2023/03/06
236999
-357612
2023-03-06
0001725160
0001725160
-120613
-
Voliotis Dimitris
2023/03/05
SVP, Clinical Development
119563
-30601
2023-03-05
0001725160
0001725160
88962
-
Voliotis Dimitris
2023/03/04
SVP, Clinical Development
119563
-30601
2023-03-04
0001725160
0001725160
88962
-
Epperly Melissa B,
2023/03/03
Chief Financial Officer
459293
-94611
2023-03-03
0001725160
0001725160
364682
-
Voliotis Dimitris
2023/03/02
SVP, Clinical Development
119563
-30601
2023-03-02
0001725160
0001725160
88962